First service to provide patients & physicians with immediate, personalized
RESEARCH TRIANGLE PARK, N.C., Oct. 4 /PRNewswire/ -- Today hundreds of millions of Americans who regularly take prescription medicines have a new tool giving them access to the most current information about the risk profile of their medications through iGuard, a wholly-owned subsidiary of Quintiles Transnational Corp.
Reinventing the way that drug safety information is communicated, iGuard is the nation's only patient-driven program that provides timely, accurate and personalized drug safety information for patients and their physicians.
iGuard enables consumers to take an active role in managing their health through this free online service. To receive personalized alerts, patients enroll online at http://www.iguard.org and follow a simple series of steps to become part of a membership network. Patients create a secure personalized iGuard profile that includes questions about their demographics, medications, medical history, and conditions that could impact their drug safety risks.
Following completion of their profile, they are immediately sent personalized risk ratings about the medications they take, including interactions between drugs. In addition, when an issue with a drug arises, such as side-effect warnings, warnings from the manufacturer or a medical journal, or changes in the prescription label, iGuard will send a drug safety alert to patients and the physician or physicians they designated in their profile.
iGuard members will be asked to update their profile on a quarterly
basis. Should a serious adverse event be suspected, iGuard will send a
MedWatch form to the patient. Patients are instructed to
Copyright©2007 PR Newswire.
All rights reserved